Webinar organized by VIVAN Therapeutics on May 2nd at 4 pm (BST) to discuss opportunities around multi-target drug discovery in oncology, in particular around KRAS resistance and Vivan Therapeutics's humanised Drosophila KRAS specific variant models for Biopharma discovery & development.

During this webinar, VIVAN will introduce a suite of KRAS variant models available to biopharma for competitive profiling, drug discovery and development. VIVAN will also demonstrate a use case for their models and discuss a groundbreaking partnership between Vivan and Dr. Albert Antolin (ICR/IDIBELL) for the development of multi target therapeutics.

The webinar is available freely via this link (starts from minute 4:30):

https://us02web.zoom.us/rec/share/aXb0EQQwH89cibR25jsnQU3dLLQ-n2aRehfJVfHM4GvI872SaeSb7x--WcuRvkhM.qQWqRuY0wKjV9iLX?startTime=1683039354000

(Passcode: 9bsv3A$n)

 

Joomla templates by a4joomla